Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30003686HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS30088900HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS30076730HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS30060933HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS30060934HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS20011880HPVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS20058749HPVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS44036219HTLV-1ENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TCGA Plot Options
Drug Information
GenePDE5A
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0000182
UniProt IDO76074
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830